The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a [form of liver disease]( ...

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...

UnitedHealth rose again, boosted by Berkshire Hathaway’s purchasing of shares last week. Dayforce soared following a report ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at ...

Today’s Forbes Daily newsletter covers the real impact from a $250 U.S. visa fee, Elon Musk and Sam Altman’s feud, Warren ...

If any investor has stood the test of time, it is Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has had a rock-star-like presence in the investing world, and his annual ...

UnitedHealth Group Incorporated (NYSE:UNH)’s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion. This was aided ...

Wall Street's main indexes rallied over the past two weeks, with the blue-chip Dow hitting an intra-day record high on Friday ...

Columbia Threadneedle’s Disciplined Core Fund returned 9.54% in Q2 2025, led by AI-fueled tech picks. Discover how stock ...

These 10 large-cap stocks gained this week, some due to positive news such as media rights deals or FDA approvals.